Patent details

EP3508204 Title: QUINAZOLIN-8-YL DERIVATIVES FOR USE IN METHODS OF TREATING MELANOMA, NON-SMALL CELL LUNG CANCER, THYROID CANCER, OVARIAN CANCER, OR COLON CANCER

Basic Information

Publication number:
EP3508204
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP191572270
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
QUINAZOLIN-8-YL DERIVATIVES FOR USE IN METHODS OF TREATING MELANOMA, NON-SMALL CELL LUNG CANCER, THYROID CANCER, OVARIAN CANCER, OR COLON CANCER
French Title of Invention:
DÉRIVÉS DE QUINAZOLIN-8-YL POUR LEUR UTILISATION DANS DES MÉTHODES DE TRAITEMENT DU MÉLANOME, DU CANCER DU POUMON NON À PETITES CELLULES, DU CANCER DE LA THYROÏDE, DU CANCER DE L'OVAIRE OU DU CANCER DU CÔLON
German Title of Invention:
CHINAZOLIN-8-YL-DERIVATE ZUR BEHANDLUNG VON MELANOMEN, NICHT-KLEINZELLIGER LUNGENKREBS, SCHILDDRÜSENKREBS, EIERSTOCKKREBS ODER DICKDARMKREBS
SPC Number:

Dates

Filing date:
22/08/2014
Grant date:
11/02/2026
EP Publication Date:
10/07/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/02/2026
EP B1 Publication Date:
11/02/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/08/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/02/2026
 
 

Name:
Neupharma, Inc.
Address:
1175 Chess Drive Suite 206, Foster City, CA 94404, United States (US)

Inventor

1

Name:
ZHU, Yong-Liang
Address:
United States (US)

2

Name:
QIAN, Xiangping
Address:
United States (US)

Priority

1

Priority Number:
201361869596 P
Priority Date:
23/08/2013
Priority Country:
United States (US)

2

Priority Number:
201361900283 P
Priority Date:
05/11/2013
Priority Country:
United States (US)

3

Priority Number:
201462000946 P
Priority Date:
20/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/519; C07D 471/04;

Publication

European Patent Bulletin

1

Issue number:
202607
Publication date:
11/02/2026
Description:
Grant (B1)

2

Issue number:
202608
Publication date:
18/02/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages